Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice
about
Respiratory viral infections and host responses; insights from genomicsThe role of viral, host, and secondary bacterial factors in influenza pathogenesisProgress of small molecular inhibitors in the development of anti-influenza virus agents.Contemporary avian influenza A virus subtype H1, H6, H7, H10, and H15 hemagglutinin genes encode a mammalian virulence factor similar to the 1918 pandemic virus H1 hemagglutinin.1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humansPleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung InjuryiTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice.Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3.Secondary Bacterial Infections Associated with Influenza PandemicsPA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice.A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages.Differential Ability of Pandemic and Seasonal H1N1 Influenza A Viruses To Alter the Function of Human Neutrophils.Redox Biology of Respiratory Viral Infections
P2860
Q28079922-54C07DA3-E8B1-4821-A010-979071DB34F3Q28082144-B74A8B43-8C7B-41D1-8993-3D512C04EA8DQ30234943-9596B348-1C19-4D9C-9B9F-5C03BA13F121Q30368757-51D33E3E-1946-4E39-A3BF-6F2CFB3363E1Q30379289-E84CF08B-7A35-4E07-8275-9264ADA86E68Q35666900-9A52000C-769A-4CDB-8CAE-C933ED87272BQ38725108-EA038166-A5DB-4917-89E4-9C31AA2B61A6Q38927479-60D16A0C-8735-49A8-8E0A-2811604D20BEQ39424504-E1AFF744-E98E-469A-9D9C-B55E7C58B780Q40706208-C206998C-97C4-43DA-9F68-BFADE36797C0Q41812704-A9F20B77-F890-42E2-A5E6-BCE62914D8ADQ42216320-8019E0F9-918D-4A09-B31F-A1AA0353CDABQ47146371-C5CBD6A7-51C4-4560-8481-156C3FC7EFD9Q56967921-5496C82D-A68C-4BF5-B40E-28AC4689906A
P2860
Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Treatment with the reactive ox ...... luenza virus infection in mice
@ast
Treatment with the reactive ox ...... luenza virus infection in mice
@en
type
label
Treatment with the reactive ox ...... luenza virus infection in mice
@ast
Treatment with the reactive ox ...... luenza virus infection in mice
@en
prefLabel
Treatment with the reactive ox ...... luenza virus infection in mice
@ast
Treatment with the reactive ox ...... luenza virus infection in mice
@en
P2093
P2860
P50
P1476
Treatment with the reactive ox ...... luenza virus infection in mice
@en
P2093
Adrian Ozinsky
Aline Sandouk
Brett W Jagger
Daniel S Chertow
John C Kash
Judith D Easterbrook
Karl Huffman
Louis M Schwartzman
Nancy B Wehr
Rebecca L Dunfee
P2860
P304
P356
10.1016/J.FREERADBIOMED.2013.10.014
P577
2013-10-17T00:00:00Z